Skip to content
BiologicalX

Comparison

Melatonin vs Thymosin Alpha-1

Side-by-side of Melatonin and Thymosin Alpha-1. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.

Effects at a glance

Melatonin

  • Shortens sleep onset latency by ~7 to 12 minutes at physiological 0.3 to 1 mg doses
  • Advances circadian phase when taken 30 to 60 minutes before target bedtime, useful for jet lag and shift work
  • Does not meaningfully increase total sleep time in healthy adults without circadian misalignment
  • Endogenous nighttime production is not suppressed by short-term exogenous supplementation
  • Higher doses (3 to 10 mg) raise plasma levels above physiological range and often increase morning grogginess
  • Effective for delayed sleep-wake phase disorder and reducing jet-lag severity in eastward travel

Thymosin Alpha-1

  • 28-amino-acid synthetic peptide identical to thymic-derived immunomodulator
  • Approved in over 35 countries as Zadaxin for hepatitis B, hepatitis C adjunct, and immune support
  • Not FDA approved in US; compounded by 503A/503B pharmacies for off-label immune support
  • Modulates T-cell maturation, NK activity, and Th1 polarization in immunocompromised states
  • Standard label dose: 1.6 mg subcutaneously twice weekly
  • Cleanest safety profile in the peptide class with hundreds of regulated trials behind it

Side-by-side

Attribute Melatonin Thymosin Alpha-1
Category supplement peptide
Also known as N-acetyl-5-methoxytryptamine Talpha1, Ta1, Zadaxin, Thymalfasin
Half-life (hr) 0.75 2
Typical dose (mg) 0.5 1.6
Dosing frequency daily, 30 to 60 minutes before target sleep time 2x weekly
Routes oral, sublingual subcutaneous, intramuscular
Onset (hr) 0.5 24
Peak (hr) 1 168
Molecular weight 232.28 3108.32
Molecular formula C13H16N2O2 C129H215N33O55
Mechanism Agonist at MT1 and MT2 receptors in the suprachiasmatic nucleus, signaling biological night and promoting sleep-onset gating plus circadian phase shifts. Synthetic peptide modulator of innate and adaptive immunity. Promotes T-cell maturation and CD4/CD8 production, modulates Th1/Th2 balance, stimulates NK cell activity, and modulates TLR2/TLR9 signaling in dendritic cells.
Legal status OTC in US; prescription in UK, EU, Japan Approved in 35+ countries as Zadaxin (hepatitis B, hepatitis C adjunct, immune support); not FDA approved in US; compounded by 503A/503B pharmacies for off-label use; not on WADA Prohibited List
WADA status allowed unknown
DEA / Rx OTC supplement in US; Rx in UK, EU, Japan, Australia Rx only via international approval or US compounding (no controlled-substance schedule)
Pregnancy Insufficient data; not routinely recommended Not recommended; insufficient data
CAS 73-31-4 62304-98-7
PubChem CID 896 16130571
Wikidata Q179243 Q913854

Safety profile

Melatonin

Common side effects

  • vivid dreams
  • morning grogginess (higher doses)
  • headache
  • dizziness

Contraindications

  • autoimmune disease (theoretical)
  • concurrent anticoagulant therapy without monitoring

Interactions

  • fluvoxamine: CYP1A2 inhibition raises melatonin levels substantially(major)
  • warfarin: possible increased bleeding risk(moderate)
  • benzodiazepines and alcohol: additive sedation(moderate)
  • antihypertensives: may alter blood pressure response(minor)

Thymosin Alpha-1

Common side effects

  • mild injection-site irritation (rare)
  • transient mild fatigue (rare)
  • occasional headache (rare)

Contraindications

  • pregnancy
  • lactation
  • active organ transplant rejection therapy
  • systemic immunosuppression for autoimmune disease (relative)
  • severe active autoimmune disease (caution)

Interactions

  • interferon-alpha: additive immune effect; used clinically in approved combination protocols(minor)
  • calcineurin inhibitors (cyclosporine, tacrolimus): theoretical destabilization of immunosuppression; avoid(major)
  • antimetabolites (azathioprine, mycophenolate): theoretical destabilization of immunosuppression; avoid(major)
  • vaccine administration: may augment vaccine response in elderly or immunocompromised; coordinate with clinician(minor)

Which Should You Take?

Melatonin comes out ahead for most readers on the criteria we weight: 2 catalogued goals, OTC, oral dosing, with a Tier-A outcome catalogued. Thymosin Alpha-1 is the right call when one of the conditionals below applies.

  • If your priority is sleep onset or sleep quality, pick Melatonin.
  • If your priority is circadian regulation, pick Melatonin.
  • If your priority is immune support, pick Thymosin Alpha-1.
  • If your priority is post-training recovery, pick Thymosin Alpha-1.

Edge case: If you want to avoid Approved in 35+ countries as Zadaxin (hepatitis B, hepatitis C adjunct, immune support); not FDA approved in US; compounded by 503A/503B pharmacies for off-label use; not on WADA Prohibited List, Melatonin is the more accessible choice.

Default choice: Melatonin. Wider use case, a Tier-A evidence outcome catalogued, and broader goal coverage. Reach for Thymosin Alpha-1 only if your priority sits squarely in the goals it owns above.

This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.

Common questions

What is the difference between Melatonin and Thymosin Alpha-1?

Melatonin and Thymosin Alpha-1 differ in category (supplement vs peptide), mechanism, and typical dosing. See the side-by-side table for full details.

Which has a longer half-life, Melatonin or Thymosin Alpha-1?

Melatonin half-life is 0.75 hours; Thymosin Alpha-1 half-life is 2 hours.

Can you stack Melatonin with Thymosin Alpha-1?

Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.

Go deeper